2019 Life Sciences Outlook: Innovation is alive and well
Transformation is accelerating, and real estate needs to keep up
The Life Sciences industry has become a key economic driver in the U.S. and a critical component of the global economy. Biotechnology and pharmaceutical firms are revolutionizing how diseases are treated and improving quality of life for millions around the globe. A new wave of medical innovation has hit the industry, with over 7,000 medicines in clinical development worldwide and a record amount of drug approvals by the FDA. Venture capital funding to Life Sciences has surged, growing 40% in the U.S. over the past year. Even with these exciting changes come challenges. As Life Sciences companies search for the brightest employees, infrastructure, affordability and competition with technology firms mean that the war for talent is tougher than ever.